2.50
Hdl Handle:
http://hdl.handle.net/10755/165733
Category:
Abstract
Type:
Presentation
Title:
Evaluation of the ONS Symptom Management Workshop on Peripheral Neuropathy
Author(s):
Armstrong, Terri
Author Details:
Terri Armstrong, University of Texas, M.D. Anderson Cancer Center, Houston, Texas, USA
Abstract:
Peripheral neuropathy (PN) is an increasingly common side effect of cancer and cancer treatment. It is estimated that nearly 20% of all patients with cancer will experience neuropathy during the course of their illness. In addition, peripheral neuropathy is a dose-limiting toxicity of three commonly used chemotherapeutic agents: Paclitaxel, Cisplatin, and Vincristine. Despite this fact, many oncology nurses are not aware of how to assess and manage this symptom in their patients. In an effort to improve knowledge of PN in oncology nurses, the Oncology Nursing Society, through a grant from Aventis Pharmaceuticals, sponsored a workshop for 200 oncology nurses. The workshop consisted of multi-disciplinary didactic lectures on anatomy, physiology of the nervous system, an overview of the causes of neuropathy, pain management, physical and occupational therapy needs, and nursing interventions. In addition, hands-on experience in exam techniques and case studies were completed. All participants received a toolkit consisting of workshop content slides, a pocket sized information card, and instruments including a reflex hammer and tuning fork to assess patients. Participants agreed to present at least one educational program on peripheral neuropathy to other nurses or to patients. To evaluate the effect of the program on participant knowledge levels, participants completed a pre- and post-test multiple choice questionnaires. This test was developed by an expert interdisciplinary panel and face validity was established by administering the pilot test to 10 oncology nurses. The test underwent minor revisions for clarity. This test was completed by attendees at the start of the workshop and at the conclusion, prior to turning in their evaluations. The percentage of correct responses increased from 76.7% to 99.6% at the completion of the program. A six-month evaluation to query their individual educational programs, and administer the workshop test and a self-efficacy questionnaire was also completed and the results will be reported. This effort to improve oncology nurse knowledge of this devastating side effect was shown to improve nurse knowledge by direct testing and can be utilized as a framework for other symptom management programs.
Repository Posting Date:
27-Oct-2011
Date of Publication:
27-Oct-2011
Conference Date:
2002
Conference Name:
27th Annual Oncology Nursing Society Congress
Conference Host:
Oncology Nursing Society
Conference Location:
Washington, D.C., USA
Note:
This is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.

Full metadata record

DC FieldValue Language
dc.type.categoryAbstracten_US
dc.typePresentationen_GB
dc.titleEvaluation of the ONS Symptom Management Workshop on Peripheral Neuropathyen_GB
dc.contributor.authorArmstrong, Terrien_US
dc.author.detailsTerri Armstrong, University of Texas, M.D. Anderson Cancer Center, Houston, Texas, USAen_US
dc.identifier.urihttp://hdl.handle.net/10755/165733-
dc.description.abstractPeripheral neuropathy (PN) is an increasingly common side effect of cancer and cancer treatment. It is estimated that nearly 20% of all patients with cancer will experience neuropathy during the course of their illness. In addition, peripheral neuropathy is a dose-limiting toxicity of three commonly used chemotherapeutic agents: Paclitaxel, Cisplatin, and Vincristine. Despite this fact, many oncology nurses are not aware of how to assess and manage this symptom in their patients. In an effort to improve knowledge of PN in oncology nurses, the Oncology Nursing Society, through a grant from Aventis Pharmaceuticals, sponsored a workshop for 200 oncology nurses. The workshop consisted of multi-disciplinary didactic lectures on anatomy, physiology of the nervous system, an overview of the causes of neuropathy, pain management, physical and occupational therapy needs, and nursing interventions. In addition, hands-on experience in exam techniques and case studies were completed. All participants received a toolkit consisting of workshop content slides, a pocket sized information card, and instruments including a reflex hammer and tuning fork to assess patients. Participants agreed to present at least one educational program on peripheral neuropathy to other nurses or to patients. To evaluate the effect of the program on participant knowledge levels, participants completed a pre- and post-test multiple choice questionnaires. This test was developed by an expert interdisciplinary panel and face validity was established by administering the pilot test to 10 oncology nurses. The test underwent minor revisions for clarity. This test was completed by attendees at the start of the workshop and at the conclusion, prior to turning in their evaluations. The percentage of correct responses increased from 76.7% to 99.6% at the completion of the program. A six-month evaluation to query their individual educational programs, and administer the workshop test and a self-efficacy questionnaire was also completed and the results will be reported. This effort to improve oncology nurse knowledge of this devastating side effect was shown to improve nurse knowledge by direct testing and can be utilized as a framework for other symptom management programs.en_GB
dc.date.available2011-10-27T12:23:56Z-
dc.date.issued2011-10-27en_GB
dc.date.accessioned2011-10-27T12:23:56Z-
dc.conference.date2002en_US
dc.conference.name27th Annual Oncology Nursing Society Congressen_US
dc.conference.hostOncology Nursing Societyen_US
dc.conference.locationWashington, D.C., USAen_US
dc.description.noteThis is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.-
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.